Your browser doesn't support javascript.
loading
Dual-tracer PET/CT protocol with [18F]FDG and [68Ga]Ga-FAPI-46 outperforms single-tracer PET/CT with [18F]FDG in different cancer types, resulting in larger functional and gross tumor volume.
Wegen, Simone; Weindler, Jasmin; Voltin, Conrad-Amadeus; van Heek, Lutz; Schomäcker, Klaus; Fischer, Thomas; Marnitz, Simone; Kobe, Carsten; Drzezga, Alexander; Roth, Katrin S.
Afiliação
  • Wegen S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
  • Weindler J; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Voltin CA; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • van Heek L; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Schomäcker K; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Fischer T; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Marnitz S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
  • Kobe C; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Drzezga A; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Roth KS; Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. katrin.roth@uk-koeln.de.
Strahlenther Onkol ; 200(1): 28-38, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37584717
ABSTRACT

PURPOSE:

Fibroblast activation protein (FAP) detected by positron-emission tomography (PET) using fibroblast activation protein inhibitor (FAPI) appears to be a promising target for cancer imaging, staging, and therapy, providing added value and strength as a complement to [18F]fluorodeoxyglucose (FDG) in cancer imaging. We recently introduced a combined single-session/dual-tracer protocol with [18F]FDG and [68Ga]Ga-FAPI for cancer imaging and staging. Malignant tissue visualization and target-to-background uptake ratios (TBRs) as well as functional tumor volume (FTV) and gross tumor volume (GTV) were assessed in the present study with single-tracer [18F]FDG PET/computed tomography (CT) and with dual-tracer [18F]FDG&[68Ga]Ga-FAPI-46 PET/CT.

METHODS:

A total of 19 patients with head and neck and gastrointestinal cancers received initial [18F]FDG-PET/CT followed by dual-tracer PET/CT after additional injection of [68Ga]Ga-FAPI-46 during the same medical appointment (on average 13.9 ± 12.3 min after injection of [18F]FDG). Two readers visually compared detection rate of malignant tissue, TBR, FTV, and GTV for tumor and metastatic tissue in single- and dual-tracer PET/CT.

RESULTS:

The diagnostic performance of dual-tracer compared to single-tracer PET/CT was equal in 13 patients and superior in 6 patients. The mean TBRs of tumors and metastases in dual-tracer PET/CTs were mostly higher compared to single-tracer PET/CT using maximal count rates (CRmax). GTV and FTV were significantly larger when measured on dual-tracer compared to single-tracer PET/CT.

CONCLUSION:

Dual-tracer PET/CT with [18F]FDG and [68Ga]Ga-FAPI-46 showed better visualization due to a generally higher TBR and larger FTV and GTV compared to [18F]FDG-PET/CT in several tumor entities, suggesting that [68Ga]Ga-FAPI-46 provides added value in pretherapeutic staging.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article